Follow The Filings

RTX RTX

Industrials, filed as RTX CORPORATION (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 3

  • 2 Owners
  • #66
  • Max 1.7%
  • Master 0.51%
  • $3.7M
  • 1 reduce

In 2026 Q3 Kentucky Trust trimmed RTX.

Who owns this now

Largest portfolio weights among holders, up to 1.7% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. Reduce 1.7%
  2. Torray Investment Partners 0.04%

Who owns RTX

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 1.7%, was 1.7% Reduce −5.5% 18,044 $3.4M History
Torray Investment Partners 0.04% Hold 1,689 $314K History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by RTX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RTX insider trades
  • None no insider bought on the open market
  • $39.5M sold by 9 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Ramsaran Maharajh EVP and General Counsel
    Sale
    $3.1M 13,655 shares at $223.92 51% of stake
    Traded Aug 18 Filed Aug 19
    ↗
  2. Troy D Brunk President, Collins Aerospace
    Sale
    $1.8M 8,557 shares at $210.29 49% of stake
    Traded Jul 24 Filed Jul 28
    ↗
  3. Tracy A Atkinson Director
    Sale
    $500K 2,295 shares at $218.05 56% of stake
    Traded Jul 27 Filed Jul 28
    ↗
  4. Kevin G DaSilva Senior VP and Treasurer
    Sale
    $1.5M 7,010 shares at $214.68 26% of stake
    Traded Jul 24–28 Filed Jul 28
    ↗
  5. Dantaya M Williams EVP & Chief HR Officer
    Sale
    $2.6M 12,713 shares at $202.83 43% of stake
    Traded Feb 23 Filed Feb 23
    ↗
  6. Neil G. Mitchill Jr. CFO
    Sale
    $7.3M 35,755 shares at $205.56 38% of stake
    Traded Feb 19 Filed Feb 23
    ↗
  7. Ramsaran Maharajh EVP and General Counsel
    Sale
    $3.1M 15,124 shares at $204.65 53% of stake
    Traded Feb 19 Filed Feb 23
    ↗
  8. Christopher T. Calio CEO
    Sale
    $13M 63,568 shares at $203.80 41% of stake
    Traded Feb 19 Filed Feb 23
    ↗
  9. Shane G Eddy President, P&W
    Sale
    $3.5M 17,527 shares at $199.16 100% of stake
    Traded Feb 12 Filed Feb 13
    ↗
  10. Kevin G DaSilva Senior VP and Treasurer
    Sale
    $1.6M 8,136 shares at $201.30 23% of stake
    Traded Feb 13 Filed Feb 13
    ↗
  11. Amy L Johnson Senior VP and Controller
    Sale
    $1.6M 8,088 shares at $195.03 42% of stake
    Traded Feb 10 Filed Feb 10
    ↗
  12. Christopher T. Calio CEO
    Sale
    $858K 4,813 shares at $178.33 5.6% of stake
    Traded Oct 27, 2025 Filed Oct 29, 2025
    ↗
  13. Neil G. Mitchill Jr. CFO
    Sale
    $874K 4,849 shares at $180.15 7.5% of stake
    Traded Oct 24, 2025 Filed Oct 28, 2025
    ↗
  14. Tracy A Atkinson Director
    Sale
    $501K 2,800 shares at $178.91 41% of stake
    Traded Oct 24, 2025 Filed Oct 28, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 share withholdings for taxes, 13 option exercises, 9 stock grants, and 6 sales back to the company.

Congress

17 members of Congress traded RTX in the last three years: 15 buys and 14 sales. 19 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $15K–$50K Mar 27 filed Jul 21
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Jan 9 filed Feb 13
  3. Markwayne Mullin R-OKJoint Buy $15K–$50K Dec 29, 2025 filed Jan 16
  4. Roger Williams R-TX-25 Buy $1K–$15K Dec 22, 2025 filed Jan 15
  5. Julie Johnson D-TX-32Joint Sell $1K–$15K Dec 18, 2025 filed Jan 15
  6. Julie Johnson D-TX-32Joint Partial sale $1K–$15K Nov 13, 2025 filed Dec 11, 2025

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A DEFINITIVE PROXY STATEMENT Filing Doc
DEFA14A DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS Filing Doc
8-K 5.02 Filing Doc

Source: SEC EDGAR submissions, updated 10 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $68.92B $80.74B $88.6B
Net income $3.2B $4.77B $6.73B
Net margin * 4.6% 5.9% 7.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $48.42B $51.13B $60.33B
Total non-current assets * $113.45B $111.73B $110.75B
Total assets $161.87B $162.86B $171.08B
Total current liabilities $46.76B $51.5B $58.78B
Total non-current liabilities * $53.66B $49.4B $45.16B
Total equity $59.8B $60.16B $65.24B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations — $7.16B $10.57B
Cash from investing — -$1.53B -$1.26B
Cash from financing — -$6.62B -$7.49B
Net change in cash $0.335B -$1.02B $1.86B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.